XML 53 R37.htm IDEA: XBRL DOCUMENT v3.25.0.1
Income Taxes (Tables)
12 Months Ended
Dec. 31, 2024
Income Taxes  
Schedule of components of income tax benefit (provision)

Year Ended December 31, 

    

2024

    

2023

    

2022

(In thousands)

Income tax benefit (provision):

Federal

$

39,821

$

36,067

$

17,484

State

15,375

13,691

9,606

Expiration of NOLs and R&D credit

(82,825)

(15,141)

(16,862)

(27,629)

34,617

10,228

Deferred tax valuation allowance

27,629

(34,617)

(10,228)

$

$

$

Schedule of reconciliation between the amount of reported income tax and the amount computed using the U.S. Statutory rate

    

2024

    

2023

    

2022

(In thousands)

Pre-tax loss

$

(157,863)

$

(141,429)

$

(112,325)

Loss at statutory rates

(33,151)

(29,700)

(23,588)

Research and development credits

(7,332)

(5,237)

(3,876)

State taxes

(15,375)

(13,691)

(9,606)

Other

662

(1,130)

11,421

Change in fair value remeasurement of contingent consideration

(1,441)

Expiration of Federal and State NOLs and R&D credits

82,825

15,141

16,862

Change in valuation allowance

(27,629)

34,617

10,228

Income tax (benefit) provision

$

$

$

Schedule of principal components of the deferred tax assets and liabilities

    

December 31, 

    

December 31, 

2024

2023

(In thousands)

Gross deferred tax assets

Net operating loss carryforwards

$

176,816

$

197,618

Tax credit carryforwards

24,718

56,830

Deferred research and development expenses

101,047

82,077

Stock-based compensation

20,940

14,671

Fixed assets

1,033

1,019

Accrued expenses and other

429

398

324,983

352,613

Gross deferred tax liabilities

IPR&D intangibles

(6,840)

(6,840)

Total deferred tax assets and liabilities

318,143

345,773

Valuation allowance

(319,756)

(347,386)

Net deferred tax liability

$

(1,613)

$

(1,613)